Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis

被引:41
作者
Carradori, Simone [1 ]
Mollica, Adriano [1 ]
De Monte, Celeste [2 ]
Granese, Arianna [2 ]
Supuran, Claudiu T. [3 ]
机构
[1] G DAnnunzio Univ Chieti Pescara, Dept Pharm, I-66100 Chieti, Italy
[2] Univ Roma La Sapienza, Dept Drug Chem & Technol, I-00185 Rome, Italy
[3] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
关键词
NO donors; selective carbonic anhydrase inhibitors; glaucoma; cancer; osteoporosis; dual pharmacological activity; NO; DERIVATIVES; DRUGS; XII;
D O I
10.3390/molecules20045667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to the recognized biological role of nitric oxide (NO) donating derivatives and of selective inhibitors of specific human carbonic anhydrase isoforms (CA, EC 4.2.1.1), promising compounds having an aromatic/heterocyclic primary sulfonamide and functionalized with NO-releasing moieties have been designed. These bifunctional agents have been tested in vitro and in vivo to assess their dual pharmacological activity. According to the encouraging results they could be proposed for the treatment of angle-open glaucoma, cancer regression and osteoporosis, in which both NO and CA activities are involved.
引用
收藏
页码:5667 / 5679
页数:13
相关论文
共 34 条
[1]   Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II [J].
Alp, Cemalettin ;
Maresca, Alfonso ;
Alp, Nurdan Alcan ;
Gultekin, Mehmet Serdar ;
Ekinci, Deniz ;
Scozzafava, Andrea ;
Supuran, Claudiu T. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (02) :294-298
[2]   Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? [J].
Alterio, Vincenzo ;
Di Fiore, Anna ;
D'Ambrosio, Katia ;
Supuran, Claudiu T. ;
De Simone, Giuseppina .
CHEMICAL REVIEWS, 2012, 112 (08) :4421-4468
[3]   Nitric oxide-releasing drugs - A novel class of effective and safe therapeutic agents [J].
Burgaud, JL ;
Ongini, E ;
Del Soldato, P .
NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL, 2002, 962 :360-371
[4]   Nitric oxide release: Part II. Therapeutic applications [J].
Carpenter, Alexis W. ;
Schoenfisch, Mark H. .
CHEMICAL SOCIETY REVIEWS, 2012, 41 (10) :3742-3752
[5]   Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII-A new scaffold for designing isoform-selective inhibitors [J].
Carradori, Simone ;
De Monte, Celeste ;
D'Ascenzio, Melissa ;
Secci, Daniela ;
Celik, Gulsah ;
Ceruso, Mariangela ;
Vullo, Daniela ;
Scozzafava, Andrea ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) :6759-6763
[6]   Novel therapies for glaucoma: a patent review 2007-2011 [J].
Carta, Fabrizio ;
Supuran, Claudiu T. ;
Scozzafava, Andrea .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (01) :79-88
[7]   Nitric Oxide (NO): An Emerging Target for the Treatment of Glaucoma [J].
Cavet, Megan E. ;
Vittitow, Jason L. ;
Impagnatiello, Francesco ;
Ongini, Ennio ;
Bastia, Elena .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (08) :5005-5015
[8]   Nitric oxide in cancer metastasis [J].
Cheng, Huiwen ;
Wang, Lei ;
Mollica, Molly ;
Re, Anthony T. ;
Wu, Shiyong ;
Zuo, Li .
CANCER LETTERS, 2014, 353 (01) :1-7
[9]   Nitric oxide - A novel therapeutic for cancer [J].
Coulter, J. A. ;
McCarthy, H. O. ;
Xiang, J. ;
Roedl, W. ;
Wagner, E. ;
Robson, T. ;
Hirst, D. G. .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2008, 19 (02) :192-198
[10]   Out of the active site binding pocket for carbonic anhydrase inhibitors [J].
D'Ambrosio, Katia ;
Carradori, Simone ;
Monti, Simona M. ;
Buonanno, Martina ;
Secci, Daniela ;
Vullo, Daniela ;
Supuran, Claudiu T. ;
De Simone, Giuseppina .
CHEMICAL COMMUNICATIONS, 2015, 51 (02) :302-305